Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Achieve Life Sciences (ACHV) Other Non-Current Assets (2016 - 2026)

Achieve Life Sciences (ACHV) has disclosed Other Non-Current Assets for 17 consecutive years, with $265000.0 as the latest value for Q1 2026.

  • Quarterly Other Non-Current Assets fell 11.67% to $265000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $265000.0 through Mar 2026, down 11.67% year-over-year, with the annual reading at $52000.0 for FY2025, 33.33% up from the prior year.
  • Other Non-Current Assets for Q1 2026 was $265000.0 at Achieve Life Sciences, up from $52000.0 in the prior quarter.
  • The five-year high for Other Non-Current Assets was $304000.0 in Q3 2024, with the low at $39000.0 in Q4 2024.
  • Average Other Non-Current Assets over 5 years is $141705.9, with a median of $94000.0 recorded in 2024.
  • The sharpest move saw Other Non-Current Assets surged 310.81% in 2024, then plummeted 78.62% in 2025.
  • Achieve Life Sciences' Other Non-Current Assets stood at $66000.0 in 2022, then soared by 39.39% to $92000.0 in 2023, then crashed by 57.61% to $39000.0 in 2024, then skyrocketed by 33.33% to $52000.0 in 2025, then skyrocketed by 409.62% to $265000.0 in 2026.
  • Per Business Quant, the three most recent readings for ACHV's Other Non-Current Assets are $265000.0 (Q1 2026), $52000.0 (Q4 2025), and $65000.0 (Q3 2025).